Avelos Therapeutics

Developer of biomarker-driven anti-cancer targeted therapies intended for cancer treatment. The company is developing targeted, biomarker-driven once-therapeutics focused on the areas of cell cycle re...

Healthcare
Seoul, South Korea
Founded 2021
24 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$21.7M
Last Round
N/A

Get the full picture

Create a free account to unlock Avelos Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required